Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Clinical Intelligence
Clinical Intelligence
RSS
Resverlogix begins dosing in phase IIb ASSURE trial
November 2, 2011
CenterWatch Staff
The CenterWatch Monthly, November 2011
November 1, 2011
CenterWatch Staff
Revalesio’s first human asthma trial shows promising results
October 31, 2011
CenterWatch Staff
FDA approves Roche’s hepatitis B test
October 31, 2011
CenterWatch Staff
Gilead submits NDA for HIV regimen
October 28, 2011
CenterWatch Staff
Nerualstem completes phase Ia MDD trial
October 27, 2011
CenterWatch Staff
FDA, ADVENTRX reach agreement for ANX-514 trial
October 27, 2011
CenterWatch Staff
FDA approves generic olanzapine injection
October 27, 2011
CenterWatch Staff
Bionovo initiates enrollment for phase III Menerba trial
October 27, 2011
CenterWatch Staff
APEPTICO successfully completes phase I AP301 trial
October 25, 2011
CenterWatch Staff
Previous
1
2
…
123
124
125
126
127
128
129
130
131
…
166
167
Next
Upcoming Events
26
Jun
Streamlining Clinical Trial Agreement Negotiations: Avoiding Common Pitfalls for Faster Signatures
27
Jun
Gene Editing at the Cutting Edge of Molecular Medicine: Clinical, Ethical, and Biosafety Concerns in CRISPR Clinical Trials
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here